X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11572) 11572
Publication (657) 657
Book Review (216) 216
Book Chapter (170) 170
Conference Proceeding (22) 22
Dissertation (9) 9
Magazine Article (9) 9
Data Set (3) 3
Journal / eJournal (2) 2
Paper (2) 2
Book / eBook (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7023) 7023
index medicus (5825) 5825
antiplatelet therapy (5354) 5354
male (3742) 3742
cardiac & cardiovascular systems (3554) 3554
female (3451) 3451
clopidogrel (3371) 3371
aspirin (3278) 3278
platelet aggregation inhibitors - therapeutic use (2845) 2845
aged (2822) 2822
middle aged (2769) 2769
percutaneous coronary intervention (2215) 2215
ticlopidine - analogs & derivatives (2069) 2069
treatment outcome (1956) 1956
risk factors (1872) 1872
peripheral vascular disease (1769) 1769
dual antiplatelet therapy (1744) 1744
thrombosis (1605) 1605
antiplatelet (1559) 1559
platelet aggregation inhibitors - adverse effects (1432) 1432
stroke (1404) 1404
myocardial-infarction (1398) 1398
platelet aggregation inhibitors - administration & dosage (1380) 1380
hematology (1300) 1300
pharmacology & pharmacy (1293) 1293
acute coronary syndromes (1291) 1291
ticlopidine - therapeutic use (1284) 1284
risk (1234) 1234
aspirin - therapeutic use (1187) 1187
stents (1163) 1163
anticoagulants (1132) 1132
drug therapy, combination (1109) 1109
prevention (1052) 1052
surgery (1045) 1045
cardiology (979) 979
time factors (979) 979
acute coronary syndrome (974) 974
therapy (947) 947
care and treatment (944) 944
mortality (937) 937
aged, 80 and over (932) 932
acute myocardial-infarction (926) 926
adult (926) 926
antiplatelet agents (924) 924
abridged index medicus (910) 910
drug-eluting stents (897) 897
platelet aggregation - drug effects (855) 855
coronary heart disease (851) 851
drug therapy (847) 847
platelet aggregation inhibitors - pharmacology (840) 840
cardiovascular (827) 827
medicine, general & internal (809) 809
retrospective studies (798) 798
ticlopidine - administration & dosage (786) 786
prospective studies (779) 779
prasugrel (775) 775
bleeding (764) 764
animals (756) 756
trial (749) 749
analysis (747) 747
medicine & public health (747) 747
myocardial infarction (734) 734
blood platelets (732) 732
anticoagulation (731) 731
aspirin - administration & dosage (728) 728
intervention (723) 723
ticagrelor (721) 721
management (719) 719
anticoagulants - therapeutic use (718) 718
cardiac patients (716) 716
clinical neurology (702) 702
warfarin (700) 700
heart attacks (694) 694
hemorrhage - chemically induced (694) 694
stent (692) 692
blood platelets - drug effects (681) 681
risk assessment (676) 676
cardiovascular diseases (664) 664
outcomes (646) 646
artery-disease (642) 642
double-blind (641) 641
cardiovascular disease (638) 638
secondary prevention (631) 631
ticlopidine - adverse effects (627) 627
stent thrombosis (616) 616
coronary artery disease (613) 613
platelets (606) 606
aggregation (600) 600
implantation (598) 598
aspirin - adverse effects (591) 591
atrial fibrillation (573) 573
patients (566) 566
follow-up studies (560) 560
metaanalysis (551) 551
acute coronary syndrome - drug therapy (532) 532
atrial-fibrillation (527) 527
internal medicine (520) 520
angioplasty (518) 518
low-dose aspirin (512) 512
fibrinolytic agents - therapeutic use (507) 507
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10896) 10896
German (226) 226
French (161) 161
Japanese (125) 125
Spanish (116) 116
Russian (99) 99
Polish (40) 40
Korean (26) 26
Czech (22) 22
Portuguese (16) 16
Italian (13) 13
Turkish (8) 8
Chinese (3) 3
Croatian (2) 2
Hungarian (2) 2
Serbian (2) 2
Slovak (2) 2
Slovenian (2) 2
Arabic (1) 1
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 09/2016, Volume 68, Issue 10, pp. 1116 - 1139
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e669S - e690S
Journal Article
Circulation, ISSN 0009-7322, 02/2013, Volume 127, Issue 5, pp. 634 - 640
Journal Article
Circulation, ISSN 0009-7322, 04/2012, Volume 125, Issue 16, pp. 2015 - 2026
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 12/2018, Volume 72, Issue 23, pp. 2915 - 2931
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2008, Volume 52, Issue 18, pp. 1502 - 1517
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2011, Volume 57, Issue 11, pp. 1264 - 1270
Journal Article
European Heart Journal, ISSN 0195-668X, 2012, Volume 33, Issue 20, pp. 2569 - 2619
Acute coronary syndromes Ischaemic heart disease | Reperfusion therapy | Primary percutaneous coronary intervention Antithrombotic therapy | Secondary prevention | Acute myocardial infarction | ST-segment elevation | Guidelines | CARDIAC & CARDIOVASCULAR SYSTEMS | BARE-METAL STENTS | Primary percutaneous coronary intervention | AMERICAN-HEART-ASSOCIATION | PERCUTANEOUS CORONARY INTERVENTION | INTRAAORTIC BALLOON COUNTERPULSATION | Antithrombotic therapy | LEFT-VENTRICULAR DYSFUNCTION | DUAL ANTIPLATELET THERAPY | SUSPECTED CARDIOGENIC-SHOCK | IN-HOSPITAL MORTALITY | Acute coronary syndromes | Ischaemic heart disease | CONVERTING-ENZYME INHIBITOR | DRUG-ELUTING STENTS | Antifibrinolytic Agents - therapeutic use | Humans | Heart Failure - physiopathology | Hyperglycemia - complications | Anxiety - prevention & control | Long-Term Care | Hemodynamics - physiology | Cardiomyopathies - etiology | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Myocardial Infarction - therapy | Out-of-Hospital Cardiac Arrest - therapy | Percutaneous Coronary Intervention - methods | Fibrinolytic Agents - therapeutic use | Electrocardiography | Cardiac Imaging Techniques - methods | Platelet Aggregation Inhibitors - therapeutic use | Dyspnea - prevention & control | Exercise Therapy - methods | Myocardial Infarction - diagnosis | Heart Failure - complications | Coronary Artery Bypass - methods | Arrhythmias, Cardiac - therapy | Pain - prevention & control | Risk Assessment | Risk Reduction Behavior | Time-to-Treatment | Emergency Treatment - methods | Biomedical Research - trends | Arrhythmias, Cardiac - etiology | Hospitalization | Out-of-Hospital Cardiac Arrest - diagnosis | Forecasting | Myocardial Reperfusion - methods | Cardiomyopathies - therapy | Myocardial Infarction - complications | Emergency Medical Services - organization & administration | General Practice - organization & administration | Hyperglycemia - therapy
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2015, Volume 65, Issue 8, pp. 777 - 786
Background The currently recommended duration of dual antiplatelet therapy (DAPT) in drug-eluting stent (DES) recipients is 12 months to reduce the risk of... 
double antiplatelet duration | percutaneous coronary angioplasty | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | THROMBOSIS | BARE-METAL STENTS | FOLLOW-UP | RISK | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | POOLED ANALYSIS | CLINICAL-OUTCOMES | PLATELET REACTIVITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Middle East | Early Termination of Clinical Trials | Coronary Restenosis - diagnosis | Coronary Artery Disease - physiopathology | Time Factors | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Everolimus | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Coronary Vessels - pathology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Europe | Coronary Restenosis - prevention & control | Treatment Outcome | Coronary Artery Disease - mortality | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Vessels - surgery | Aged | Percutaneous Coronary Intervention - adverse effects | Aspirin
Journal Article